• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

维持性静脉输液的液体管理。

Fluid Stewardship of Maintenance Intravenous Fluids.

机构信息

Department of Pharmacy, St. Joseph's/Candler Health System, Savannah, GA, USA.

Department of Clinical and Administrative Pharmacy, University of Georgia College of Pharmacy, Albany, GA, USA.

出版信息

J Pharm Pract. 2022 Oct;35(5):769-782. doi: 10.1177/08971900211008261. Epub 2021 Apr 8.

DOI:10.1177/08971900211008261
PMID:33827313
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8497650/
Abstract

Despite the frequent use of maintenance intravenous fluids (mIVF) in critically ill patients, limited guidance is available. Notably, fluid overload secondary to mIVF mismanagement is associated with significant adverse patient outcomes. The Four Rights (right drug, right dose, right duration, right patient) construct of fluid stewardship has been proposed for the safe evaluation and use of fluids. The purpose of this evidence-based review is to offer practical insights for the clinician regarding mIVF selection, dosing, and duration in line with the Four Rights of Fluid Stewardship.

摘要

尽管在危重症患者中经常使用维持静脉输液(mIVF),但可用的指导有限。值得注意的是,由于 mIVF 管理不当导致的液体超负荷与患者的不良预后显著相关。液体管理的四项权利(正确的药物、正确的剂量、正确的持续时间、正确的患者)结构已被提出,用于安全评估和使用液体。本循证综述的目的是为临床医生提供有关 mIVF 选择、剂量和持续时间的实用见解,以符合液体管理的四项权利。

相似文献

1
Fluid Stewardship of Maintenance Intravenous Fluids.维持性静脉输液的液体管理。
J Pharm Pract. 2022 Oct;35(5):769-782. doi: 10.1177/08971900211008261. Epub 2021 Apr 8.
2
Isotonic versus hypotonic solutions for maintenance intravenous fluid administration in children.等渗溶液与低渗溶液用于儿童维持性静脉输液
Cochrane Database Syst Rev. 2014 Dec 18;2014(12):CD009457. doi: 10.1002/14651858.CD009457.pub2.
3
Perioperative administration of buffered versus non-buffered crystalloid intravenous fluid to improve outcomes following adult surgical procedures.围手术期给予缓冲与非缓冲晶体静脉输液以改善成人外科手术后的结局。
Cochrane Database Syst Rev. 2017 Sep 21;9(9):CD004089. doi: 10.1002/14651858.CD004089.pub3.
4
Fluid overload, de-resuscitation, and outcomes in critically ill or injured patients: a systematic review with suggestions for clinical practice.危重症或受伤患者的液体超负荷、液体复苏解除及预后:一项系统综述并提出临床实践建议
Anaesthesiol Intensive Ther. 2014 Nov-Dec;46(5):361-80. doi: 10.5603/AIT.2014.0060.
5
Prescription of Controlled Substances: Benefits and Risks管制药品的处方:益处与风险
6
Single induction dose of etomidate versus other induction agents for endotracheal intubation in critically ill patients.在危重症患者中,依托咪酯单次诱导剂量与其他诱导剂用于气管插管的比较。
Cochrane Database Syst Rev. 2015 Jan 8;1(1):CD010225. doi: 10.1002/14651858.CD010225.pub2.
7
Association of hydroxyethyl starch administration with mortality and acute kidney injury in critically ill patients requiring volume resuscitation: a systematic review and meta-analysis.羟乙基淀粉给药与需要容量复苏的危重症患者死亡率和急性肾损伤的关系:系统评价和荟萃分析。
JAMA. 2013 Feb 20;309(7):678-88. doi: 10.1001/jama.2013.430.
8
Hydroxyethyl starch (HES) versus other fluid therapies: effects on kidney function.羟乙基淀粉(HES)与其他液体疗法:对肾功能的影响。
Cochrane Database Syst Rev. 2013 Jul 23;2013(7):CD007594. doi: 10.1002/14651858.CD007594.pub3.
9
Intravenous fluids for reducing the duration of labour in low risk nulliparous women.用于缩短低风险初产妇产程的静脉输液。
Cochrane Database Syst Rev. 2013 Jun 18;2013(6):CD007715. doi: 10.1002/14651858.CD007715.pub2.
10
Individualized de-resuscitation and diuresis strategies in hospitalized patients: A narrative review.住院患者的个体化撤机和利尿策略:一篇叙述性综述。
Am J Health Syst Pharm. 2025 Aug 18. doi: 10.1093/ajhp/zxaf217.

引用本文的文献

1
Advances in resuscitation and deresuscitation.复苏与终止复苏的进展
Curr Opin Crit Care. 2025 Mar 7;31(3):277-84. doi: 10.1097/MCC.0000000000001267.
2
Unsupervised machine learning analysis to identify patterns of ICU medication use for fluid overload prediction.用于识别ICU药物使用模式以预测液体超负荷的无监督机器学习分析。
Pharmacotherapy. 2025 Feb;45(2):76-86. doi: 10.1002/phar.4642. Epub 2025 Jan 3.
3
Chemotherapy-induced acute kidney injury: epidemiology, pathophysiology, and therapeutic approaches.化疗所致急性肾损伤:流行病学、病理生理学及治疗方法
Front Nephrol. 2024 Aug 9;4:1436896. doi: 10.3389/fneph.2024.1436896. eCollection 2024.
4
Unsupervised machine learning analysis to identify patterns of ICU medication use for fluid overload prediction.用于识别ICU药物使用模式以预测液体超负荷的无监督机器学习分析。
medRxiv. 2024 Mar 22:2024.03.21.24304663. doi: 10.1101/2024.03.21.24304663.
5
Machine learning vs. traditional regression analysis for fluid overload prediction in the ICU.机器学习与传统回归分析在 ICU 中预测液体超负荷的比较。
Sci Rep. 2023 Nov 10;13(1):19654. doi: 10.1038/s41598-023-46735-3.
6
Hidden Fluids in Plain Sight: Identifying Intravenous Medication Classes as Contributors to Intensive Care Unit Fluid Intake.一目了然的隐匿液体:确定静脉用药类别是重症监护病房液体摄入的因素
Hosp Pharm. 2022 Apr;57(2):230-236. doi: 10.1177/00185787211016339. Epub 2021 May 19.
7
Early Diuretics for De-resuscitation in Septic Patients With Left Ventricular Dysfunction.早期使用利尿剂用于左心室功能不全的脓毒症患者的脱机治疗
Clin Med Insights Cardiol. 2022 May 13;16:11795468221095875. doi: 10.1177/11795468221095875. eCollection 2022.

本文引用的文献

1
Low-chloride- versus high-chloride-containing hypertonic solution for the treatment of subarachnoid hemorrhage-related complications: The ACETatE (A low ChloriE hyperTonic solution for brain Edema) randomized trial.低氯与高氯含高渗溶液治疗蛛网膜下腔出血相关并发症:ACETatE(用于脑水肿的低氯高渗溶液)随机试验
J Intensive Care. 2020 May 4;8:32. doi: 10.1186/s40560-020-00449-0. eCollection 2020.
2
Guidelines for the Acute Treatment of Cerebral Edema in Neurocritical Care Patients.神经危重症患者脑水肿急性治疗指南。
Neurocrit Care. 2020 Jun;32(3):647-666. doi: 10.1007/s12028-020-00959-7.
3
Antiviral Drugs and Acute Kidney Injury (AKI).抗病毒药物与急性肾损伤(AKI)
Infect Disord Drug Targets. 2019;19(4):375-382. doi: 10.2174/1871526519666190617154137.
4
Fluid Stewardship During Critical Illness: A Call to Action.危重病期间的液体管理:行动呼吁。
J Pharm Pract. 2020 Dec;33(6):863-873. doi: 10.1177/0897190019853979. Epub 2019 Jun 30.
5
Contrast-Associated Acute Kidney Injury.对比剂相关急性肾损伤
N Engl J Med. 2019 May 30;380(22):2146-2155. doi: 10.1056/NEJMra1805256.
6
Impact of Obesity on Acyclovir-Induced Nephrotoxicity.肥胖对阿昔洛韦诱导的肾毒性的影响。
Open Forum Infect Dis. 2019 Mar 7;6(4):ofz121. doi: 10.1093/ofid/ofz121. eCollection 2019 Apr.
7
Pharmacological interventions for the prevention of contrast-induced acute kidney injury in high-risk adult patients undergoing coronary angiography: a systematic review and meta-analysis of randomised controlled trials.药物干预预防高危成年患者冠状动脉造影检查后对比剂诱导急性肾损伤:随机对照试验的系统评价和荟萃分析。
Open Heart. 2019 Jan 25;6(1):e000864. doi: 10.1136/openhrt-2018-000864. eCollection 2019.
8
A clinical pharmacist survey of prophylactic strategies used to prevent adverse events of lipid-associated formulations of amphotericin B.临床药师对用于预防两性霉素B脂质体剂型不良事件的预防策略的调查。
Infect Dis (Lond). 2019 May;51(5):380-383. doi: 10.1080/23744235.2019.1568546. Epub 2019 Feb 18.
9
The incidence, risk factors, and clinical outcomes of acute kidney injury (staged using the RIFLE classification) associated with intravenous acyclovir administration.静脉用阿昔洛韦给药相关急性肾损伤(采用 RIFLE 分类分期)的发生率、风险因素和临床结局。
Ren Fail. 2018 Nov;40(1):687-692. doi: 10.1080/0886022X.2018.1487866.
10
Analysis of the risk factors for contrast-induced nephropathy in over-aged patients receiving coronary intervention.分析接受冠状动脉介入治疗的超龄患者对比剂肾病的危险因素。
Exp Biol Med (Maywood). 2018 Aug;243(12):970-975. doi: 10.1177/1535370218799973.